Newly Found Alzheimer’s Plaque Type Linked to Early-Onset Disease

These “coarse-grained” plaques resemble those that clog up the brain’s blood vessels in a different disease, pointing to links between the vascular system and the neurodegenerative disease.

Written byIan Le Guillou
| 4 min read
amyloid-beta amyloid plaque alzheimer's disease coarse-grained neurodegeneration ab40 ab42

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: The newly described plaque (green, red, and yellow) with its direct connection with blood vessels (blue)
B.D.C. BOON ET AL., ACTA NEUROPATHOLOGICA, DOI:10.1007/S00401-020-02198-8, 2020

Scientists have discovered a type of amyloid-β plaque in the brains of people with early-onset Alzheimer’s disease that has not been observed before. These “coarse-grained” plaques, described in a study published last week in Acta Neuropathologica, have a different structure, composition, and distribution from the typical amyloid plaques that have been well-studied in the disease.

“For a different study, we were looking into the neuroinflammatory response in early-onset AD cases,” says Baayla Boon, a PhD candidate in pathology at Amsterdam UMC and the lead author of the study. Examining post-mortem brain slices from this small group of similar cases, she noticed a lot of plaques that appeared darker than expected under the microscope. “We realized that these plaques look different from what we actually knew,” she ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ian le guillou

    Ian is a freelance journalist based in Paris, covering health and biomedical research. After hanging up his lab coat in 2012, Ian worked for several years in communications for medical research charities in the UK before going freelance.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies